rs569851503

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM1BP4_Moderate

The NM_000100.4(CSTB):​c.29A>C​(p.Gln10Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,529,408 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q10E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000058 ( 0 hom. )

Consequence

CSTB
NM_000100.4 missense

Scores

2
6
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: -0.0130

Publications

1 publications found
Variant links:
Genes affected
CSTB (HGNC:2482): (cystatin B) The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and kininogens. This gene encodes a stefin that functions as an intracellular thiol protease inhibitor. The protein is able to form a dimer stabilized by noncovalent forces, inhibiting papain and cathepsins l, h and b. The protein is thought to play a role in protecting against the proteases leaking from lysosomes. Evidence indicates that mutations in this gene are responsible for the primary defects in patients with progressive myoclonic epilepsy (EPM1). One type of mutation responsible for EPM1 is the expansion in the promoter region of this gene of a CCCCGCCCCGCG repeat from 2-3 copies to 30-78 copies. [provided by RefSeq, Jul 2016]
CSTB Gene-Disease associations (from GenCC):
  • Unverricht-Lundborg syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • keratolytic winter erythema
    Inheritance: AD Classification: MODERATE Submitted by: PanelApp Australia
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • autosomal recessive hypohidrotic ectodermal dysplasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 10 uncertain in NM_000100.4
BP4
Computational evidence support a benign effect (MetaRNN=0.2044406).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSTBNM_000100.4 linkc.29A>C p.Gln10Pro missense_variant Exon 1 of 3 ENST00000291568.7 NP_000091.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSTBENST00000291568.7 linkc.29A>C p.Gln10Pro missense_variant Exon 1 of 3 1 NM_000100.4 ENSP00000291568.6
CSTBENST00000640406.1 linkc.29A>C p.Gln10Pro missense_variant Exon 1 of 2 2 ENSP00000492672.1
CSTBENST00000675996.1 linkn.90A>C non_coding_transcript_exon_variant Exon 1 of 3
CSTBENST00000639959.1 linkc.-5A>C upstream_gene_variant 5 ENSP00000492123.1

Frequencies

GnomAD3 genomes
AF:
0.0000658
AC:
10
AN:
152016
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000158
AC:
2
AN:
126306
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000213
Gnomad AMR exome
AF:
0.0000430
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000581
AC:
8
AN:
1377284
Hom.:
0
Cov.:
31
AF XY:
0.00000442
AC XY:
3
AN XY:
679436
show subpopulations
African (AFR)
AF:
0.000237
AC:
7
AN:
29576
American (AMR)
AF:
0.0000287
AC:
1
AN:
34792
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24700
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34504
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77614
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40244
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5394
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1073124
Other (OTH)
AF:
0.00
AC:
0
AN:
57336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152124
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41508
American (AMR)
AF:
0.00
AC:
0
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5142
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67964
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000756
ExAC
AF:
0.0000284
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
Dec 02, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 10, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Jul 19, 2019
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Nov 20, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.29A>C (p.Q10P) alteration is located in exon 1 (coding exon 1) of the CSTB gene. This alteration results from a A to C substitution at nucleotide position 29, causing the glutamine (Q) at amino acid position 10 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Progressive myoclonic epilepsy Uncertain:1
Oct 17, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 10 of the CSTB protein (p.Gln10Pro). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with CSTB-related conditions. ClinVar contains an entry for this variant (Variation ID: 193045). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.073
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.26
T;.
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.68
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.60
T;T
M_CAP
Pathogenic
0.30
D
MetaRNN
Benign
0.20
T;T
MetaSVM
Benign
-0.70
T
PhyloP100
-0.013
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-3.1
D;.
REVEL
Benign
0.17
Sift
Uncertain
0.0080
D;.
Sift4G
Uncertain
0.037
D;.
Polyphen
0.58
P;.
Vest4
0.19
MutPred
0.43
Gain of glycosylation at Q10 (P = 0.0075);Gain of glycosylation at Q10 (P = 0.0075);
MVP
0.51
MPC
0.54
ClinPred
0.92
D
GERP RS
-0.77
PromoterAI
0.025
Neutral
Varity_R
0.95
gMVP
0.60
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs569851503; hg19: chr21-45196122; API